Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01822847 · ClinicalTrials.gov registry record
Physiological Response of Cortisol to Cardiac Catheterization
A clinical trial, sponsored by Creighton University.
- Completed
- Registry status
- 24
- Enrollment target
NCT01822847: Completed study, sponsored by Creighton University.
NCT01822847 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01822847 has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
Cortisol is essential for survival. The importance of cortisol response is most apparent in patients with partial or complete deficiency of glucocorticoids during stressful events such as illness or surgery.
Primary Outcome
On the day of the procedure a total of 4 venous blood samples for random plasma cortisol level will be obtained. Blood will be drawn at 5 minutes prior to the procedure, at 30 minutes and 60 minutes during the cardiac catheterization. Another sample will be drawn in 3 hours after cardiac catheterization prior to the patients discharge. a cortisol level will be drawn at a "nonstressful" visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-03 |
| Est. Completion | 2014-04 |
What the finished NCT01822847 record still lists
NCT01822847 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01822847 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01822847 about?
NCT01822847 is a clinical study titled "Physiological Response of Cortisol to Cardiac Catheterization". Cortisol is essential for survival. The importance of cortisol response is most apparent in patients with partial or complete deficiency of glucocorticoids during stressful events such as illness or surgery.
What is the current status of trial NCT01822847?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-03. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01822847?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia